Investors are Betting Against Ariad Pharmaceuticals (ARIA), Should You? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 59 mins ago
Investors are Betting Against Ariad Pharmaceuticals (ARIA), Should You?
Wider-than-Expected Q1 Loss at MannKind - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 39 mins ago
MannKind's (MNKD) loss of 14 cents per share in the first quarter of 2014 was wider than the Zacks Consensus Estimate by a penny.
Tesaro, Inc. (TSRO) Looks Strong as Stock Rallies 21% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue May 13, 7:44AM CDT
Tesaro, Inc. (TSRO) was a big mover last session, as its shares surge 21% on the day.
ARIAD to Present at UBS Global Healthcare Conference
Business Wire - Tue May 13, 6:35AM CDT
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the UBS Global Healthcare Conference being held in New York City. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company's business on Tuesday, May 20, 2014, at 4:00 p.m. (ET).
84.9% Return Seen to Date on SmarTrend Ariad Pharmaceuticals Call (ARIA)
Comtex SmarTrend(R) - Mon May 12, 12:12PM CDT
SmarTrend identified an Uptrend for Ariad Pharmaceuticals (NASDAQ:ARIA) on November 22nd, 2013 at $3.67. In approximately 6 months, Ariad Pharmaceuticals has returned 84.88% as of today's recent price of $6.79.
Ariad Pharmaceuticals, Inc Earnings: Cloudy Future Drains Enthusiasm
Leo Sun, The Motley Fool - Motley Fool - Mon May 12, 9:20AM CDT
Shares of Ariad Pharmaceuticals fell nearly 5% on May 7 after the company reported its first-quarter earnings. The stock has fallen more than 60% over the past 12 months due to safety concerns about its only...
PharmAthene (PIP) Catches Eye: Stock Rises 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 12, 8:46AM CDT
PharmAthene (PIP) was a big mover last session, as the company saw its shares rise over 6% on the day.
Corcept Therapeutics (CORT) in Focus: Stock Rises 5.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 12, 8:39AM CDT
Corcept Therapeutics Incorporated (CORT) was a big mover last session, as its shares rose almost 6% on the day.
Spectrum Pharma Up on Q1 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 12, 8:00AM CDT
Spectrum Pharma's (SPPI) first quarter 2014 earnings of a penny per share were flat year over year.
NPS Pharmaceuticals (NPSP) Jumps: Stock Up 13.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 12, 7:51AM CDT
NPS Pharmaceuticals, Inc. (NPSP) was a big mover last session, as its shares rose almost 14% on the day.
ARIAD's Q1 Loss Narrows - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 08, 11:00AM CDT
ARIAD Pharmaceuticals Inc. (ARIA) reported narrower-than-expected loss in the first quarter of 2014.
Wider-than-Expected Q1 Loss at Nektar - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 08, 10:20AM CDT
Nektar (NKTR) reported a loss of 37 cents per share in the first quarter of 2014, wider than the Zacks Consensus Estimate of a loss of 35 cents.
Allergan Beats on Earnings, Guidance Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 07, 12:50PM CDT
Allergan, Inc. (AGN) reported first quarter 2014 earnings of $1.18 per share.
Ariad Pharmaceuticals' Loss Shrinks 23% as Iclusig Revenue Rises
Sean Williams, The Motley Fool - Motley Fool - Wed May 07, 11:31AM CDT
Controversial small-cap biopharmaceutical company Ariad Pharmaceuticals took steps in the right direction to rebuilding its Iclusig brand this morning with the release of its first-quarter earnings results . For the quarter, total revenue...
Ariad Pharmaceuticals (ARIA) Stock Falls Despite Revenue Beat
at The Street - Wed May 07, 9:51AM CDT
Ariad Pharmaceuticals (ARIA) fell Wednesday despite the company's first-quarter results that beat analysts' expectations.
Today’s Top Biotech Stories: Aegerion, GW, and Ariad Pharmaceuticals
Leo Sun, The Motley Fool - Motley Fool - Wed May 07, 8:11AM CDT
Let's take a closer look at three stocks -- Aegerion Pharmaceuticals , GW Pharmaceuticals , and Ariad Pharmaceuticals -- which could make waves across the health care sector this Wednesday morning. Aegerion slumps on weak earnings...
ARIAD Reports First Quarter 2014 Financial Results and Development Progress
Business Wire - Wed May 07, 6:35AM CDT
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig(R) (ponatinib) and licensing agreements. The Company also provided an update on corporate developments.
Look for Shares of Ariad Pharmaceuticals to Potentially Pullback after Yesterday's 5.53% Rise
Comtex SmarTrend(R) - Mon May 05, 4:57PM CDT
Ariad Pharmaceuticals (NASDAQ:ARIA) traded in a range yesterday that spanned from a low of $7.26 to a high of $7.73. Yesterday, the shares gained 5.5%, which took the trading range above the 3-day high of $7.68 on volume of 14.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
4 Big Stocks on Traders' Radars
at The Street - Mon May 05, 1:55PM CDT
Here's a look at how to trade some of the most active stocks on the market today.
Most active Nasdaq-traded stocks
AP - Mon May 05, 12:22PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.: